[1]CurrentPatentAssignee:APOTEXINC-US2013/274474,2013,A1Locationinpatent:Paragraph0079-0080
64168-68-9
4045-29-8
793667-32-0
915921-51-6
91595-79-8
1420816-40-5
500199-09-7 | Thiophene, 2-bromo-3-tetradecyl- | AA00IMB0 | MFCD31618101
15937-81-2 | 1,3-Di(2-pyridyl)propane | AA00IMEA | MFCD31618133
674773-07-0 | Ranelic acid strontium salt hydrate | AA00IMHN | MFCD12031997
223796-38-1 | 1-(5-Phenylpyridin-3-yl)-1,4-diazepane | AA00IMM5 | MFCD27956143
240799-53-5 | 3-(2,2-diethoxyethyl)-1-(2-methoxypyridine-3-carbonyl)urea | AA00IMPY | MFCD00127029
246022-02-6 | 1-[2-(2,4-dichlorophenyl)-2-oxoethyl]pyridin-1-ium iodide | AA00IMSP | MFCD00140544
250713-93-0 | ethyl 2-[2-(furan-2-amido)-1,3-thiazol-4-yl]benzoate | AA00IMVP | MFCD00141943
226954-82-1 | ethyl 6-hydroxy-2,4-diphenyl-4,5-dihydropyrimidine-5-carboxylate | AA00IMY7 | MFCD00794725
477846-99-4 | 4-(4-methylphenyl)-2-{4-[(4-nitrophenyl)methoxy]phenyl}pyrimidine | AA00IN1H | MFCD02186943
860610-43-1 | N'-[2-(1,1-dioxo-1lambda6-thiomorpholin-4-yl)acetyl]cyclohexanecarbohydrazide | AA00IN3N | MFCD03305378
